Cyxtera Results Presentation Deck
Q2 2022 Results
Core revenue increased by $9.4 million, or 5.9%, YoY to $168.8 million
Transaction Adjusted EBITDA decreased by $2.3 million or 3.8% year-
over-year, to $60.0 million, principally due to SG&A costs. 2022 includes
public company costs not in existence in 2021.
Cyxtera
($ in Millions)
Recurring Revenue
Non-Recurring Revenue
Total Revenue
Cost of Revenue
As a % of Revenue
Gross Profit
% Margin
Total SG&A
As a % of Revenue
Other (1)
EBITDA
% Margin
Transaction Adjustments
Transaction Adjusted EBITDA (²)
% Margin
Rent (net of adjustments)
Transaction Adjusted EBITDAR (3)
% Margin
Capital Expenditures
As a % of Revenue
(1) Q2 22 includes $1.3M in restructuring, impairment, site closures and related cost. Q2 21 includes $58.9M in restructuring, impairment, site closures and related cost
(2) Earnings Before Interest, Taxes, Depreciation, Amortization;
(3) Earnings Before Interest, Taxes, Depreciation, Amortization & Rent;
Q2'22
$174.2
9.9
$184.1
$98.4
53.5%
$85.7
46.5%
$34.7
18.8%
$1.3
$49.7
27.0%
$10.3
$60.0
32.6%
$14.8
$74.8
40.6%
$30.4
16.5%
Q2'21
$167.3
8.1
$175.4
$95.5
54.4%
$79.9
45.6%
$22.9
13.1%
$58.9
($1.9)
(1.1%)
$64.3
$62.3
35.5%
$15.3
$77.6
44.3%
$13.7
7.8%
YOY Change
4.1%
21.9%
4.9%
3.0%
(99 bps)
7.2%
99 bps
51.4%
578 bps
ΝΑ
ΝΑ
(3.8%)
(295 bps)
(3.7%)
(363 bps)
121.2%
868 bps
11View entire presentation